FDG-PET in radiotherapy treatment planning: Pandora's box?

This publication has 12 references indexed in Scilit:

• Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Role of fusion in radiotherapy treatment planning
  Seminars in Nuclear Medicine, 2003
• Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed Tomography
  New England Journal of Medicine, 2003
• Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2003
• The impact of 18 FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET)
  Radiotherapy and Oncology, 2002
• Clinical Impact of ¹⁸F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non–Small-Cell Lung Cancer: A Prospective Study
  Journal of Clinical Oncology, 2001
• The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer
  Radiotherapy and Oncology, 2000
• Consensus statement: Guidelines for PSA following radiation therapy1
  International Journal of Radiation Oncology*Biology*Physics, 1997
• The Will Rogers Phenomenon
  New England Journal of Medicine, 1985